ENTITY
Pharmaessentia Corp

Pharmaessentia Corp (6446 TT)

124
Analysis
Health Care • Taiwan
PharmaEssentia Corporation develops and distributes therapeutic products for treatment in human disease. The Company develops drugs to treat hepatitis, chronic myeloid leukemia (CML), essential thrombocythemia (ET), myeloid fibrosis (MF), polycythemia vera (PV), hepatitis and cancer.
more
bullish•Quantitative Analysis
•12 Aug 2024 07:05

TWSE Foreign Holding Weekly (Aug 9th): TSMC, Hon Hai, Quanta Computer, Unimicron Tech, Mediatek

We analyzed TWSE foreign holding data for the past week and highlighted foreign holding changes in TSMC, Hon Hai, Quanta Computer, Unimicron Tech,...

Logo
325 Views
Share
bullish•Pharmaessentia Corp
•12 Aug 2024 06:40

Taiwan Top 50 ETF Rebalance Preview: One Change Right at the Cusp

There could be one change for the Taiwan Top 50 ETF in September. Review cutoff is two weeks away and there are some stocks that are close to the...

Logo
456 Views
Share
bearish•Quantitative Analysis
•05 Aug 2024 07:05

TWSE Foreign Holding Weekly (Aug 2nd): Umc, TSMC, Hon Hai, Mediatek, Quanta Computer, Unimicron Tech

We analyzed TWSE foreign holding data for the past week and highlighted foreign holding changes in Umc, TSMC, Hon Hai, Mediatek, Quanta Computer,...

Logo
327 Views
Share
bullish•Quantitative Analysis
•22 Jul 2024 07:05

TWSE Foreign Holding Weekly (Jul 19th): Wiwynn, TSMC, Quanta Computer, Mediatek, Gigabyte Tech

We analyzed TWSE foreign holding data for the past week and highlighted foreign holding changes in Wiwynn, TSMC, Quanta Computer, Mediatek,...

Logo
361 Views
Share
bullish•Pharmaessentia Corp
•25 Jun 2024 22:32

Pharmaessentia Corp (6446 TT): Starts 2024 on Strong Note; Reports First Operating Profit in 1Q24

​Pharmaessentia reports strong 1Q24 results with increased revenue, decreased operating expenses, and first-time operating profit. Geography and...

Logo
461 Views
Share
x